Ritonavir: Difference between revisions
Jump to navigation
Jump to search
imported>David E. Volk (New page: {{subpages}} right|thumb|350px|{{#ifexist:Template:Ritonavir structure.jpg/credit|{{Ritonavir structure.jpg/credit}}<br/>|}}Ritonavir '''Ritonavir''', s...) |
imported>David E. Volk m (→External Links) |
||
Line 10: | Line 10: | ||
== External Links == | == External Links == | ||
* {{DailyMed}} | * {{DailyMed}} | ||
* | * {{MedMaster}} | ||
* {{DrugBank}} |
Revision as of 12:27, 5 March 2008
Ritonavir, sold under the brand names Norvir® and Norvir Sec®, and as a mixture with Lopinavir called Kaletra®, is a protease inhibitor used to treat HIV/AIDS by disrupting the reproductive cycle of the virus. Ritonavir binds to and inhibits the HIV-1 viral proteinase enzyme which prevents cleavage of the gag-pol polyprotein, resulting in noninfectious, immature viral particles. Protease inhibitors like ritonavir are almost always used in combination with at least two other anti-HIV drugs.
Its chemical name is 1,3-thiazol-5-ylmethyl N-[(2S,3S,5S)-3-hydroxy-5-[[(2S)-3-methyl-2-[[methyl-[(2-propan- 2-yl-1,3-thiazol-4-yl)methyl]carbamoyl]amino]butanoyl]amino]-1,6-di(phenyl)hexan- 2-yl]carbamate and its chemical formula is C37H48N6O5S2.
External Links
- Ritonavir - FDA approved drug information (drug label) from DailyMed (U.S. National Library of Medicine).
- Template:MedMaster
- Template:DrugBank